ATX
vs
E
EPE
ATX
Over the past 12 months, ATX has significantly outperformed EPE, delivering a return of +53% compared to the EPE's 0% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
ATX
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
Amplia Therapeutics Ltd
ASX:ATX
|
0.13
AUD
|
|||||
|
E
|
Epizyme Inc
F:EPE
|
559
EUR
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
ATX, EPE
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
|
Amplia Therapeutics Ltd
Revenue
|
|||||||||||
|
E
|
Epizyme Inc
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
ATX, EPE
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
|
Amplia Therapeutics Ltd
ASX:ATX
|
|||||||||
|
E
|
Epizyme Inc
F:EPE
|
|||||||||
Compare company's free cash flow with its competitors.
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Amplia Therapeutics Ltd | ||||
|
E
|
Epizyme Inc | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
ATX, EPE
Performance Gap
ATX, EPE
Performance By Year
ATX, EPE
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
